Guardian Life Guardian TV Facebook Instagram Twitter

GSK completes divestment of drinks, distribution business

By Helen Oji   |   05 October 2016   |   2:22 am
GlaxoSmithKline

GlaxoSmithKline

GlaxoSmithKline (GSK) Consumer Nigeria Plc has announced the completion of divestment of the drinks bottling and distribution business to Suntory Beverage & Food Nigeria Limited.

This, according to the firm, follows the recent approvals from the shareholders and the Nigeria Securities & Exchange Commission (SEC) to divest the drink and beverage business.

With the approval, GSK has transferred ownership of the drinks business in Nigeria to Suntory Beverage & Food Nigeria Ltd effective October 1, 2016.


The company pointed out that the new GSK Consumer Healthcare Company (retained business) consists of the Consumer Healthcare Wellness, Oral Healthcare, Nutrition categories and Pharmaceutical business, with a portfolio of leading healthcare brands.

It added that the retained brands include Sensodyne, Macleans, Panadol, Horlicks, Andrews Liver Salts, Voltaren, Otrivin and CAC 1000.

“Today, we announce the completion of the divestment of the GSK Consumer Nigeria plc drinks bottling and distribution business to Suntory Beverage & Food Nigeria Limited (SBFN).  This follows the recent approvals from the shareholders and the Nigeria Securities & Exchange Commission (SEC).

“Following this approval, GSK has transferred ownership of the Drinks business in Nigeria to Suntory Beverage & Food Nigeria Ltd effective 1st October 2016.

“The new GSK Consumer Healthcare Company (retained business) consists of the Consumer Healthcare Wellness, Oral Healthcare and Nutrition categories and Pharmaceutical business, with a portfolio of leading healthcare brands.

“The retained brands include Sensodyne, Macleans, Panadol, Horlicks, Andrews Liver Salts, Voltaren, Otrivin and CAC 1000. GSK Nigeria will continue to be listed on the Nigerian Stock Exchange (NSE).”


In this article:
GlaxoSmithKline


You may also like